Stefano Marletta

Dr. Stefano Marletta

Verona University-Medicine Department
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SMStefano Marletta
Stefano Marletta
Nicola FuscoNicola Fusco
Nicola Fusco
EMEnrico Munari
Enrico Munari
Claudio LuchiniClaudio Luchini
Claudio Luchini
ALESSIA CIMADAMOREALESSIA CIMADAMORE
ALESSIA CIMADAMORE
Albino EccherAlbino Eccher
Albino Eccher
Background. Innovative drugs targeting the PD1/PD-L1 axis have opened promising scenarios in modern cancer therapy. Plenty of assays and scoring systems have been developed for the evaluation of PD-L1 immunohistochemical expression, so far considered the most reliable therapeutic predictive marker. Methods. By gathering the opinion of acknowledged experts in dedicated fields of pathology, we sought to update the currently available evidence on PD-L1 assessment in various types of tumors. Results. Robust data were progressively collected for several anatomic districts and leading international agencies to approve specific protocols: among these, TPS with 22C3, SP142 and SP263 clones in lung cancer; IC with SP142 antibody in breast, lung and urothelial tumors; and CPS with 22C3/SP263 assays in head and neck and urothelial carcinomas. On the other hand, for other malignancies, such as gastroenteric neoplasms, immunotherapy has been only recently introduced, often for particular histotypes, so specific guidelines are still lacking. Conclusions. PD-L1 immunohistochemical scoring is currently the basis for allowing many cancer patients to receive properly targeted therapies. While protocols supported by proven data are already available for many tumors, dedicated studies and clinical trials focusing on harmonization of the topic in other still only partially explored fields are surely yet advisable.

21 February 2024 in American Journal of Clinical Pathology
Verified
Journal Article
Closed access
PDF file
SMStefano Marletta
Stefano Marletta
Albino EccherAlbino Eccher
Albino Eccher
FMFilippo Maria Martelli
Filippo Maria Martelli
NSNicola Santonicco
Nicola Santonicco
IGIlaria Girolami
Ilaria Girolami
APAnil Parwani
Anil Parwani
Objectives: The high incidence of prostate cancer causes prostatic samples to significantly affect pathology laboratories workflow and turnaround times (TATs). Whole-slide imaging (WSI) and artificial intelligence (AI) have both gained approval for primary diagnosis in prostate pathology, providing physicians with novel tools for their daily routine. Methods: A systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines was carried out in electronic databases to gather the available evidence on the application of AI-based algorithms to prostate cancer. Results: Of 6290 articles, 80 were included, mostly (59%) dealing with biopsy specimens. Glass slides were digitized to WSI in most studies (89%), roughly two-thirds of which (66%) exploited convolutional neural networks for computational analysis. The algorithms achieved good to excellent results about cancer detection and grading, along with significantly reduced TATs. Furthermore, several studies showed a relevant correlation between AI-identified histologic features and prognostic predictive variables such as biochemical recurrence, extraprostatic extension, perineural invasion, and disease-free survival. Conclusions: The published evidence suggests that AI can be reliably used for prostate cancer detection and grading, assisting pathologists in the time-consuming screening of slides. Further technologic improvement would help widening AI’s adoption in prostate pathology, as well as expanding its prognostic predictive potential.

6 February 2023 in Pathology - Research and Practice
Verified
Journal Article
Closed access
SMStefano Marletta
Stefano Marletta
VLVincenzo L’iMperio
Vincenzo L’iMperio
Albino EccherAlbino Eccher
Albino Eccher
PAPietro Antonini
Pietro Antonini
NSNicola Santonicco
Nicola Santonicco
LPLiron Pantanowitz
Liron Pantanowitz

26 April 2023 in Cancers
Verified
Journal Article
Open access
PDF file
NCNicolò Caldonazzi
Nicolò Caldonazzi
PRPaola Chiara Rizzo
Paola Chiara Rizzo
Albino EccherAlbino Eccher
Albino Eccher
IGIlaria Girolami
Ilaria Girolami
Giuseppe Nicolò FanelliGiuseppe Nicolò Fanelli
Giuseppe Nicolò Fanelli
SMStefano Marletta
Stefano Marletta
One of the most relevant prognostic factors in cancer staging is the presence of lymph node (LN) metastasis. Evaluating lymph nodes for the presence of metastatic cancerous cells can be a lengthy, monotonous, and error-prone process. Owing to digital pathology, artificial intelligence (AI) applied to whole slide images (WSIs) of lymph nodes can be exploited for the automatic detection of metastatic tissue. The aim of this study was to review the literature regarding the implementation of AI as a tool for the detection of metastases in LNs in WSIs. A systematic literature search was conducted in PubMed and Embase databases. Studies involving the application of AI techniques to automatically analyze LN status were included. Of 4584 retrieved articles, 23 were included. Relevant articles were labeled into three categories based upon the accuracy of AI in evaluating LNs. Published data overall indicate that the application of AI in detecting LN metastases is promising and can be proficiently employed in daily pathology practice.

16 September 2023 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
CFChiara Frascarelli
Chiara Frascarelli
GBGiuseppina Bonizzi
Giuseppina Bonizzi
CMCamilla Rosella Musico
Camilla Rosella Musico
EMEltjona Mane
Eltjona Mane
CCCristina Cassi
Cristina Cassi
Nicola FuscoNicola Fusco
Nicola Fusco
Background. Biobanks are vital research infrastructures aiming to collect, process, store, and distribute biological specimens along with associated data in an organized and governed manner. Exploiting diverse datasets produced by the biobanks and the downstream research from various sources and integrating bioinformatics and “omics” data has proven instrumental in advancing research such as cancer research. Biobanks offer different types of biological samples matched with rich datasets comprising clinicopathologic information. As digital pathology and artificial intelligence (AI) have entered the precision medicine arena, biobanks are progressively transitioning from mere biorepositories to integrated computational databanks. Consequently, the application of AI and machine learning on these biobank datasets holds huge potential to profoundly impact cancer research. Methods. In this paper, we explore how AI and machine learning can respond to the digital evolution of biobanks with flexibility, solutions, and effective services. We look at the different data that ranges from specimen-related data, including digital images, patient health records and downstream genetic/genomic data and resulting “Big Data” and the analytic approaches used for analysis. Results. These cutting-edge technologies can address the challenges faced by translational and clinical research, enhancing their capabilities in data management, analysis, and interpretation. By leveraging AI, biobanks can unlock valuable insights from their vast repositories, enabling the identification of novel biomarkers, prediction of treatment responses, and ultimately facilitating the development of personalized cancer therapies. Conclusions. The integration of biobanking with AI has the potential not only to expand the current understanding of cancer biology but also to pave the way for more precise, patient-centric healthcare strategies.

22 October 2021 in Diagnostic Cytopathology
Verified
Journal Article
Closed access
PDF file
NSNicola Santonicco
Nicola Santonicco
SMStefano Marletta
Stefano Marletta
LPLiron Pantanowitz
Liron Pantanowitz
Guido FaddaGuido Fadda
Guido Fadda
Giancarlo TronconeGiancarlo Troncone
Giancarlo Troncone
Albino EccherAlbino Eccher
Albino Eccher